Showing 20 of 200 recruiting trials for “large-granular-lymphocyte-leukemia”
ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML
RecruitingNCT03568266 ↗
Pharmacogenomics of Asparaginase Induced Hepatotoxicity
👨⚕️ Houda Alachkar, Ph.D., University of Southern California📍 1 site📅 Started May 2018View details ↗
RecruitingNCT03501576 ↗
Evaluation of Human Immune Responses Vaccination in Patients With Lymphoma
RecruitingNCT03342144 ↗
Study of the Use of Venetoclax in Participants With Chronic Lymphocytic Leukemia (CLL) Under Real-Life Setting
RecruitingNCT03375619 ↗
Long-term Follow-up Study of Patients Receiving CAR-T Cells
211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia
👨⚕️ Brenda M. Sandmaier, Fred Hutch/University of Washington Cancer Consortium📍 1 site📅 Started Oct 2017View details ↗
A Study of Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
👨⚕️ Leland Metheny, MD, University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center📍 7 sites📅 Started Jul 2017View details ↗
CD19 CAR-T Consolidation Therapy for Acute Lymphoblastic Leukemia
Ibrutinib and Blinatumomab in Treating Patients With Relapsed or Refractory B Acute Lymphoblastic Leukemia
RecruitingNCT03197259 ↗
Chronic Lymphocytic Leukemia Registry Study - Multicenter Prospective National Study
Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases
CARPALL: Immunotherapy with CD19+CD22 CAR T-cells for CD19+ and CD22+ Acute Lymphoblastic Leukaemia
KIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT Children
👨⚕️ Michael Pulsipher, MD, Children's Hospital Los Angeles📍 11 sites📅 Started Oct 2015View details ↗
A Long-term Extension Study of PCI-32765 (Ibrutinib)
👨⚕️ Janssen Research & Development, LLC Clinical Trial, Janssen Research & Development, LLC📍 174 sites📅 Started Sep 2013View details ↗
ALL SCTped FORUM - Pharmacogenomic Study (add-on Study)
👨⚕️ Christina Peters, Prof. MD PhD, St. Anna Kinderspital, Vienna, Austria📍 4 sites📅 Started Apr 2013View details ↗
Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
RecruitingNCT04028531 ↗
Understanding Chronic Lymphocytic Leukemia
← PreviousPage 10 of 10
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →